Prevalence of factor V Leiden in south Tunisian blood donors

Journal of Thrombosis and Thrombolysis

Volumn 32, Issue 1, 2011, Pages 116-119

  Maalej, Lobna ^a   Hadjkacem, Basma ^b   Amor, Ikram Ben ^a   Smaoui, Mariem ^a   Gargouri, Ali ^b   Gargouri, Jalel ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

Author keywords

(G1691A) mutation; APCR test; Blood donors; Factor V Leiden; PCR RFLP; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SEROPREVALENCE; TUNISIAN;

AMINO ACID SUBSTITUTION; BLOOD DONORS; FACTOR V; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; TUNISIA;

EID: 80052502490     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0582-9     Document Type: Article

References (21)

1. EL-Shami K, Griffiths E, Streiff M (2007) Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist 12(5):518-523 (Pubitemid 350012114)
2. Kalkanli S, Ayyildiz O, Tiftik N et al (2006) Factor V Leiden mutation in venous thrombosis in southeast turkey. Angiology 57(2):193-196 (Pubitemid 44438571)
3. Vossen CY, Conard J, Fontcuberta J et al (2005) Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European prospective cohort on thrombophilia (EPCOT). Thromb Haemostasis 3:459-464 (Pubitemid 41632870)
4. Martinelli I, Mannucci PM, Stefano VD et al (1998) Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 92(7): 2353-2358 (Pubitemid 28452977)
5. Jun ZJ, Ping T, Lei Y et al (2006) Prevalence of Factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haem 28:111-116
6. Franco RF, Reitsma PH (2001) Genetic risk factors of venous thrombosis. Hum Genet 109:369-384 (Pubitemid 33064516)
7. Rosendorff A, Dorfman DM (2007) Activated protein C resistance and Factor V Leiden. Arh Pathol Lab Med 131:866-871 (Pubitemid 46906378)
8. Baba-Ahmed M, Gal GL, Couturaud F et al (2007) High frequency of Factor V Leiden in surgical patients with symptomatic venous thrombo-embolism despite prophylaxis. Thromb Haemostasis 97:171-175 (Pubitemid 46592134)
9. Lee DH, Henderson PA, Blajchman MA (1996) Prevalence of Factor V Leiden in a Canadian blood donor population. Can Med Assoc J 155(3):285-289 (Pubitemid 26268000)
10. Mazoyer E, Ripoll L, Gueguen R et al (2009) Prevalence of Factor V Leiden or prothrombin G20210A mutation in a French population of large size chosen for the history non thrombotic: geographical distribution and age. Blood Coagul Fibrin 20(7): 503-510
11. Sottilotta G, Mammi C, Furlo G et al (2007) High incidence of Factor V Leiden and prothrombin G20210A in healthy southern Italians. Neuro Endocrinol Lett 28(5):699-703
12. Rahimi Z, Asad VR, Mozafari H et al (2008) Prevalence of Factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran. Thromb Thrombolys 25:280-283 (Pubitemid 351772731)
13. Palomo I, Segovia F, Parra D et al (2009) Low prevalence of Factor V Leiden and the prothrombin G20210A mutation in a healthy population from the central-south region of Chile. Rev Bras Hematol Hemoter 31(3):143-146
14. Nusier MK, Radaideh AM, Ababneh NA et al (2007) Prevalence of Factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians. Neuro Endocrinol Lett 28(5):699-703
15. Irani-Hakime N, Tamim GH, Finan RR et al (2000) High prevalence of Factor V mutation (Leiden) in the Eastern Mediterranean. Clin Chem 46(1):134-136 (Pubitemid 30090977)
16. Lucotte G, Mercier G (2001) Population genetics of Factor V Leiden in Europe. Blood Cells Mol Dis 27(2):362-367 (Pubitemid 32547831)
17. Mathonnet F, Nadifi S, Serazin-Leroy V et al (2002) Absence of Factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy moroccan population. Thromb Haemostasis 88(6):1073-1074 (Pubitemid 36018802)
18. Bouaziz-Borgi L, Almawi WY, Mtiraoui N et al (2006) Distinct association of Factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon. Am J Hematol 81(8):641-643 (Pubitemid 44066178)
19. Ajem A, Slama A, Slama FBH et al (2009) Prevalence of Factor V Leiden mutation in patients with thrombosis in Tunisia. East Mediterr Health J 15(6):1483-1488
20. Almawi WY, Keleshian SH, Borgi L et al (2005) The prevalence ranged from Factor V G1691A (Leiden) and prothrombin G20210A single nucleotide. Thromb Thrombolys 3:163-168 (Pubitemid 41662502)
21. Antoniadi T, Hatzis T, Kroupis C et al (1999) Prevalence of Factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 61:265-267 (Pubitemid 29355025)